Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Investigation of Ki67 biomarker

Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Investigation of Ki67 biomarker ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
17 Dec 2012

Effects of obesity in breast cancer patients

Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA
Effects of obesity in breast cancer patients ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )
14 Dec 2012

The AZURE translational study

Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
The AZURE translational study ( Prof Robert Coleman	 - Weston Park Hospital, University of Sheffield, UK )
14 Dec 2012

Diagnosis of blood cancer after a breast cancer diagnosis

Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA
Diagnosis of blood cancer after a breast cancer diagnosis ( Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA )
14 Dec 2012

Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer

Prof Ron Bose – Washington University School of Medicine, St. Louis, USA
Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer ( Prof Ron Bose – Washington University School of Medicine, St. Louis, USA )
12 Dec 2012

Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment

Prof Ron Bose - Washington University School of Medicine, St Louis, USA
Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment ( Prof Ron Bose - Washington University School of Medicine, St Louis, USA )
12 Dec 2012

Colon cancer microenvironments preventing invasion and metastasis

Dr Makoto Mark Taketo – Kyoto University Graduate School of Medicine, Japan
Colon cancer microenvironments preventing invasion and metastasis ( Dr Makoto Mark Taketo – Kyoto University Graduate School of Medicine, Japan )
20 Nov 2012

RAB5, master regulator of tumour, mesenchymal invasive programmes

Dr Giorgio Scita – IFOM University of Milan, Italy
RAB5, master regulator of tumour, mesenchymal invasive programmes ( Dr Giorgio Scita – IFOM University of Milan, Italy )
20 Nov 2012

Regulation of self-renewal in cancer stem cells

Prof Pier Giuseppe Pelicci – European Institute of Oncology, Milan, Italy
Regulation of self-renewal in cancer stem cells ( Prof Pier Giuseppe Pelicci – European Institute of Oncology, Milan, Italy )
20 Nov 2012

Interplay between pathologies of ovarian cancer and genomics

Prof David Huntsman – University of British Columbia, Vancouver, Canada
Interplay between pathologies of ovarian cancer and genomics ( Prof David Huntsman – University of British Columbia, Vancouver, Canada )
15 Nov 2012

Benefit of exercise to cancer survivors

Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands
Benefit of exercise to cancer survivors ( Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands )
14 Nov 2012

The importance of hereditary genes to cancer susceptibility

Dr Judy Garber – Dana Farber Cancer Institute, Boston, USA
The importance of hereditary genes to cancer susceptibility ( Dr Judy Garber – Dana Farber Cancer Institute, Boston, USA )
14 Nov 2012